Skip to main content
C.I.MEDICAL CO.,LTD. logo

C.I.MEDICAL CO.,LTD. — Investor Relations & Filings

Ticker · 3540 ISIN · JP3346190006 T Wholesale and retail trade
Open in API
Filings indexed 59 across all filing types
Latest filing 2026-04-10 Regulatory Filings
Country JP Japan
Listing T 3540

About C.I.MEDICAL CO.,LTD.

https://ci-medical.co.jp/english/

C.I.MEDICAL CO.,LTD. is a company specializing in the development, manufacturing, and mail-order sales of dental and medical supplies. It operates as a comprehensive, one-stop supplier for medical institutions, with a primary focus on dental clinics and laboratories. The company's extensive product catalog features over 60,000 items, ranging from general medical equipment to its own line of innovative dental care products, such as toothbrushes. C.I.MEDICAL is committed to providing reliable, high-quality, and affordable products designed to improve oral care and prevent disease. The company supports its innovation through in-house capabilities, including 3D design labs.

Recent filings

Filing Released Lang Actions
訂正親会社等状況報告書（内国会社）－第26期(2025/01/01－2025/12/31)
Regulatory Filings Classification · 1% confidence The document is a correction report (“訂正報告書”) of the parent company status report (“親会社等状況報告書”) filed under the Japanese Financial Instruments and Exchange Act. It is a statutorily required regulatory submission rather than a management change notice, earnings release, or other specific category. It does not contain a summary or announcement of a report publication, nor is it an ESG, dividend, or capital structure update. Therefore it falls under the fallback ‘Regulatory Filings’ category.
2026-04-10 Japanese
親会社等状況報告書（内国会社）－第26期(2025/01/01－2025/12/31)
Regulatory Filings Classification · 1% confidence The document is titled “親会社等状況報告書” filed under the Japanese Financial Instruments and Exchange Act (Art.24‐7) with the Kinki Finance Bureau, covering the 2025 fiscal year. It provides statutory corporate information (parent/subsidiary relationships, shareholding, directors) and references attaching the B/S, P/L, and other Companies Act schedules. It is not a full Annual Report (10‐K) or Earnings Release, nor an AGM material or management discussion. It is a statutory regulatory filing under Japanese law that does not neatly fit a more specific category, so it falls into the general Regulatory Filings fallback.
2026-03-31 Japanese
意見表明報告書
M&A Activity Classification · 1% confidence The document is an 'Opinion Statement Report' (意見表明報告書) filed by C.I. Medical Co., Ltd. in response to a tender offer (公開買付け) initiated by Air Water Inc. This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan when a company expresses its opinion on a tender offer for its shares. It details the background, purpose, and the board's decision-making process regarding the tender offer. It is not a report publication announcement (RPA) because it is the primary regulatory document itself, nor is it a standard earnings release or annual report. It fits the definition of a regulatory filing (RNS) as it is a specific statutory disclosure document.
2025-08-08 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the semi-annual report (Interim Report) for the period ending June 30, 2025. While it references the interim report, it is a standalone regulatory filing confirming the validity of the financial statements. Given the specific nature of this regulatory confirmation document, it falls under the 'Regulatory Filings' category as it does not constitute the full interim report itself nor a simple announcement of publication.
2025-08-08 Japanese
半期報告書－第26期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) for the company '株式会社歯愛メディカル' (C.I. MEDICAL CO.,LTD.) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management analysis, and audit information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-08 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the company's 25th Annual General Meeting (AGM) held on March 21, 2025, in accordance with financial regulations. Section 2 details the resolutions, which include the approval of the year-end dividend (剰余金処分の件) and the election of directors and auditors. This content—reporting the results of a shareholder vote at a general meeting—directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the primary focus is reporting the *results* of the votes, not providing the AGM presentation materials (AGM-R). The document length is short (2191 chars), but its nature is a formal regulatory filing reporting specific vote outcomes, making DVA the most precise fit.
2025-03-31 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.